Cancer Research

Can a Blood Test Predict Lung Cancer Five Years Early?
Tech & Innovation Can a Blood Test Predict Lung Cancer Five Years Early?

The traditional medical model for managing respiratory oncology has long relied on late-stage symptom detection, which unfortunately often means that patients are diagnosed only after the disease has significantly progressed and become more difficult to treat effectively. However, a significant

Zetagen Therapeutics Pioneers Bone Regeneration for Cancer
Research & Development Zetagen Therapeutics Pioneers Bone Regeneration for Cancer

The diagnosis of metastatic cancer often carries a heavy burden of finality, where the primary objective of medical intervention shifts almost exclusively toward palliative care and the management of inevitable decline. For decades, patients grappling with the spread of malignancy to their skeletal

AI Transforms Drug Discovery and Cancer Diagnostics
Tech & Innovation AI Transforms Drug Discovery and Cancer Diagnostics

The sheer complexity of human cellular interaction often dwarfs the capacity of even the most seasoned medical professional to synthesize millions of data points into a single, cohesive diagnosis. Researchers like Dr. Amber Simpson at the University of Alberta are spearheading a movement that

AI Predicts Meningioma Recurrence Using Routine Pathology
Tech & Innovation AI Predicts Meningioma Recurrence Using Routine Pathology

The subtle architecture of a brain tumor often conceals a lethal potential that remains invisible to even the most experienced human eyes during a standard microscopic examination. For patients diagnosed with meningioma, the most common primary brain tumor in adults, the journey following surgery

Can AI Predict Radiation Doses for Prostate Cancer?
Tech & Innovation Can AI Predict Radiation Doses for Prostate Cancer?

The field of nuclear medicine is currently witnessing a transformative shift as researchers leverage advanced artificial intelligence to solve the long-standing challenge of unpredictable radiation absorption in cancer patients. Recent breakthroughs led by Dr. Amit Nautiyal and a dedicated team of

Darlifarnib Shows High Efficacy in KRAS-Mutant Cancers
Research & Development Darlifarnib Shows High Efficacy in KRAS-Mutant Cancers

The persistent struggle against KRAS mutations has long been a defining battle in modern oncology, representing a target once thought to be totally unreachable by conventional drug design due to the protein's lack of accessible binding pockets. For decades, clinicians and researchers faced a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later